Site Management Organization Market

Chapter Outlines

Chapter 2 is an executive summary of the key insights captured during our research. It offers a high-level view on the likely evolution of the site management organizations market in the short to mid-term, and long term.

Chapter 3 provides a general introduction to SMOs, featuring information on their working model and major differences between a SMO and CRO. Further, it provides details related to the various services offered by SMOs. Additionally, it highlights the advantages offered by SMOs acting as one-stop-shops. The chapter concludes with a discussion on the anticipated opportunity areas for SMOs and inputs on their projected growth in the coming years.

Chapter 4 features a detailed review of the current market landscape of around 250 companies offering clinical trial site management services. Additionally, it features an in-depth analysis of service providers, based on a number of relevant parameters, such as year of establishment, company size (in terms of employee count) and location of headquarters. The chapter also covers details about type of site management service(s) offered (site identification and selection, study feasibility, study protocol development, patient recruitment, patient retention, project management, regulatory support, clinical monitoring, site management, clinical trial data management, patient follow-up, real-time enquiry / information support, study contract, budget and expense management / contract negotiation, hiring / training study investigator, logistics management, quality control and quality assurance and others), therapeutic expertise of service providers (oncological disorders, CNS disorders, infectious diseases, respiratory disorders, cardiovascular diseases, endocrine disorders, gastrointestinal disorders, musculoskeletal diseases, immunological disorders, dermatological disorders and others) and geographical reach of the companies.

Chapter 5 presents an insightful competitiveness analysis of the site management organizations, located in North America, Europe and Asia-Pacific. The companies are further segmented based on their employee count, into three categories, namely small (1-200 employees), mid-sized (201-500 employees) and large (>500 employees) across these geographies. The analysis compares the service providers on the basis of various parameters, such as site management services offered, therapeutic expertise, geographical reach and year of establishment. In the chapter, stakeholder entities have been plotted on a 2×2 matrices, having a company’s experience (based on its year of establishment) (abscissa) and company competitiveness (ordinate) as the two axes. 

Chapter 6 provides detailed profiles of the prominent players (shortlisted based on a proprietary criterion) that are active in offering clinical trial site management services in North America. Each profile provides an overview of the company, information related to its site management service portfolio, and details on recent developments, as well as an informed future outlook.

Chapter 7 provides detailed profiles of the prominent players (shortlisted based on a proprietary criterion) that are active in offering clinical trial site management services in Europe. Each profile provides an overview of the company, information related to its site management service portfolio, and details on recent developments, as well as an informed future outlook.

Chapter 8 provides detailed profiles of the prominent players (shortlisted based on a proprietary criterion) that are active in offering clinical trial site management services in Asia-Pacific. Each profile provides an overview of the company, information related to its site management service portfolio, and details on recent developments, as well as an informed future outlook.

Chapter 9 features an analysis of the various collaborations and partnerships that have been inked by stakeholders engaged in this domain, during the period 2016-2021 (till August). It includes a brief description of the partnership models (including service alliances, clinical trial agreements, acquisitions, product / technology integration agreements, technology utilization agreements, R&D agreements, mergers, joint ventures, clinical trial site agreements, technology licensing agreements and others) adopted by stakeholders in this domain. Further, it comprises of analysis based on year of agreement, type of agreement, focus area and most active player(s) (in terms of number of partnerships inked). Further, the chapter includes a world map representation of all the deals inked in this field in the period 2016-2021, highlighting both intercontinental and intracontinental partnership activity.

Chapter 10 presents details on various investments received by various players engaged in clinical trial site management domain. It also includes an analysis of the funding instances that have taken place in the market, during the period 2015-2021 (till August), highlighting the growing interest of the venture capital community and other strategic investors within this market.

Chapter 11 provides a detailed analysis of completed, ongoing, and planned clinical studies during the period 2016-2021 (till August), to present clinical trial key insights, highlighting prevalent trends across various relevant parameters, such as trial registration year, number of enrolled patients, trial status, trial phase, type of sponsor and geographical distribution of number of trials and enrolled patient population.

Chapter 12 provides an informed estimate of the annual demand for clinical study participants, taking into account the target patient population in ongoing and planned clinical trials, sponsored by both industry and non-industry players.

Chapter 13 presents an insightful market forecast analysis, highlighting the likely growth of the site management organizations market till the year 2035. In order to provide details on the future opportunity, our projections have been segmented on the basis of [A] therapeutic areas (oncological disorders, CNS disorders, infectious diseases, respiratory disorders, cardiovascular diseases, endocrine disorders, gastrointestinal disorders, musculoskeletal diseases, immunological disorders and others), [B] clinical trial phases (phase I, phase II, phase III and phase IV), [C] clinical trial components (site management, onsite monitoring, project management, data management, regulatory affairs, logistics, quality control and others), [D] types of interventions (therapeutics, devices and surgical procedure) and [E] key geographical regions (North America, Europe, Asia-Pacific, Latin America, MENA and RoW). 

Chapter 14 summarizes the overall report. In this chapter, we have provided a list of key takeaways from the report, and expressed our independent opinion related to the research and analysis described in the previous chapters.

Chapter 15 provides the transcripts of interviews conducted with representatives from renowned organizations that are engaged in the site management domain. In this chapter, we have presented the details of our conversation with Vinod Gyanchandani (Country Head - Clinical Operations, GDD Experts), Marisa Vico (Medical Director and Operations Manager, SMO – Dra. Marisa Vico) and Eugene Winifred (Project Manager, Syncretic Clinical Research Services).

Chapter 16 is an appendix, that provides tabulated data and numbers for all the figures included in the report.

Chapter 17 is an appendix that provides the list of companies and organizations that have been mentioned in the report.

Table Of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Site Management Organizations
3.3. Role of Site Management Organizations in Clinical Trials
3.4. Services Offered by Site Management Organizations
3.5. Advantages of One-Stop-Shops
3.6. Concluding Remarks

4. COMPETITIVE LANDSCAPE
4.1. Chapter Overview
4.2. Site Management Organizations: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Service(s) Offered
4.2.5. Analysis by Therapeutic Expertise
4.2.6. Analysis by Geographical Reach

5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Parameters
5.3. Methodology
5.4. Site Management Organizations: Company Competitiveness Analysis
5.4.1. Competitiveness Analysis: Site Management Organizations in North America
5.4.1.1. Competitiveness Analysis: Small Companies in North America
5.4.1.2. Competitiveness Analysis: Mid-sized Companies in North America
5.4.1.3. Competitiveness Analysis: Large Companies in North America

5.4.2. Competitiveness Analysis: Site Management Organizations in Europe
5.4.2.1. Competitiveness Analysis: Small Companies in Europe
5.4.2.2. Competitiveness Analysis: Mid-sized Companies in Europe
5.4.2.3. Competitiveness Analysis: Large Companies in Europe

5.4.3. Competitiveness Analysis: Site Management Organizations in Asia-Pacific and Rest of the World
5.4.3.1. Competitiveness Analysis: Small Companies in Asia-Pacific and Rest of the World
5.4.3.2. Competitiveness Analysis: Mid-sized Companies in Asia-Pacific and Rest of the World
5.4.3.3. Competitiveness Analysis: Large Companies in Asia-Pacific and Rest of the World

6. COMPANY PROFILES: SITE MANAGEMENT ORGANIZATIONS IN NORTH AMERICA
6.1. Chapter Overview
6.2. FOMAT Medical Research
6.2.1. Company Overview
6.2.2. Clinical Trial Site Management Services
6.2.3. Recent Developments and Future Outlook

6.3. Parexel
6.3.1. Company Overview
6.3.2. Clinical Trial Site Management Services
6.3.3. Recent Developments and Future Outlook

6.4. Pharm-Olam
6.4.1. Company Overview
6.4.2. Clinical Trial Site Management Services
6.4.3. Recent Developments and Future Outlook
6.5. Veristat
6.5.1. Company Overview
6.5.2. Clinical Trial Site Management Services
6.5.3. Recent Developments and Future Outlook

6.6. WCCT Global
6.6.1. Company Overview
6.6.2. Clinical Trial Site Management Services
6.6.3. Recent Developments and Future Outlook

6.7. Worldwide Clinical Trials
6.7.1. Company Overview
6.7.2. Clinical Trial Site Management Services
6.7.3. Recent Developments and Future Outlook

7. COMPANY PROFILES: SITE MANAGEMENT ORGANIZATIONS IN EUROPE
7.1. Chapter Overview
7.2. CROMSOURCE
7.2.1. Company Overview
7.2.2. Clinical Trial Site Management Services
7.2.3. Recent Developments and Future Outlook

7.3. Fidelis Research
7.3.1. Company Overview
7.3.2. Clinical Trial Site Management Services
7.3.3. Recent Developments and Future Outlook

7.4. Scandinavian CRO
7.4.1. Company Overview
7.4.2. Clinical Trial Site Management Services
7.4.3. Recent Developments and Future Outlook
7.5. TFS HealthScience
7.5.1. Company Overview
7.5.2. Clinical Trial Site Management Services
7.5.3. Recent Developments and Future Outlook

7.6. Trialbee
7.6.1. Company Overview
7.6.2. Clinical Trial Site Management Services
7.6.3. Recent Developments and Future Outlook

8. COMPANY PROFILES: SITE MANAGEMENT ORGANIZATIONS IN ASIA-PACIFIC
8.1. Chapter Overview
8.2. CMIC Group
8.2.1. Company Overview
8.2.2. Clinical Trial Site Management Services
8.2.3. Recent Developments and Future Outlook

8.3. George Clinical
8.3.1. Company Overview
8.3.2. Clinical Trial Site Management Service
8.3.3. Recent Developments and Future Outlook

8.4. Tigermed
8.4.1. Company Overview
8.4.2. Clinical Trial Site Management Services
8.4.3. Recent Developments and Future Outlook

8.5. Veeda Clinical Research
8.5.1. Company Overview
8.5.2. Clinical Trial Site Management Services
8.5.3. Recent Developments and Future Outlook

9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Site Management Organizations: Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Year and Type of Partnership
9.3.4. Analysis by Focus Area
9.3.5. Most Active Players: Analysis by Number of Partnerships
9.3.6. Geographical Analysis
9.3.6.1. Region-wise Distribution
9.3.6.2. Country-wise Distribution

10. FUNDING AND INVESTMENT ANALYSIS
10.1. Chapter Overview
10.2. Types of Funding
10.3. Site Management Organizations: Funding and Investment Analysis
10.3.1. Analysis by Year of Investment
10.3.2. Analysis by Amount Invested
10.3.3. Analysis by Type of Funding
10.3.4. Year-wise Analysis by Type of Funding and Amount Invested
10.3.5. Most Active Players: Analysis by Number of Funding Instances
10.3.6. Most Active Investors: Analysis by Number of Funding Instances
10.3.7. Analysis by Type of Investor
10.3.8. Analysis by Geography

11. KEY INSIGHTS FROM CLINICAL TRIAL ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Site Management Organizations: Clinical Trial Key Insights
11.3.1. Analysis by Trial Registration Year
11.3.2. Analysis by Trial Registration Year and Enrolled Patient Population
11.3.3. Analysis by Trial Status
11.3.4. Analysis by Trial Registration Year and Trial Status
11.3.5. Analysis by Trial Phase
11.3.6. Analysis by Trial Phase and Enrolled Patient Population
11.3.7. Analysis by Trial Registration Year and Trial Phase (in term of Number of Clinical Trials)
11.3.8. Analysis by Trial Registration Year and Trial Phase (in terms of Number of Enrolled Patient Population)
11.3.9. Analysis by Type of Sponsor / Collaborator
11.3.10. Geographical Analysis by Number of Clinical Trials
11.3.11. Geographical Analysis by Enrolled Patient Population

12. ANALYSIS OF DEMAND FOR CLINICAL TRIAL PARTICIPANTS
12.1. Chapter Overview
12.2. Methodology and Key Assumptions
12.3. Global Demand for Clinical Trial Participants: Analysis by Enrolled Patient Population
12.3.1. Analysis of Demand by Trial Phase
12.3.2. Analysis of Demand by Therapeutic Area
12.3.3. Geographical Demand by Enrolled Patient Population

13. MARKET FORECAST AND OPPORTUNITY ANALYSIS
13.1. Chapter Overview
13.2. Forecast Methodology and Key Assumptions
13.3. Global Site Management Organizations Market, 2021-2035
13.4. Site Management Organizations Market, 2021 and 2035: Distribution by Therapeutic Area
13.5. Site Management Organizations Market, 2021-2035: Distribution by Trial Phase
13.6. Site Management Organizations Market, 2021-2035: Distribution by Clinical Trial Components
13.7. Site Management Organizations Market, 2021-2035: Distribution by Type of Intervention
13.8. Site Management Organizations Market, 2021 and 2035: Distribution by Region
13.8.1. Site Management Organizations Market, 2021 and 2035: Distribution by Country
13.8.2. Site Management Organizations Market in North America, 2021-2035
13.8.2.1. Site Management Organizations Market in the US, 2021-2035
13.8.2.2. Site Management Organizations Market in Canada, 2021-2035
13.8.2.3. Site Management Organizations Market in Rest of North America, 2021-2035

13.8.3. Site Management Organizations Market in Europe, 2021-2035
13.8.3.1. Site Management Organizations Market in the UK, 2021-2035
13.8.3.2. Site Management Organizations Market in France, 2021-2035
13.8.3.3. Site Management Organizations Market in Germany, 2021-2035
13.8.3.4. Site Management Organizations Market in Spain, 2021-2035
13.8.3.5. Site Management Organizations Market in Italy, 2021-2035
13.8.3.6. Site Management Organizations Market in Rest of Europe, 2021-2035

13.8.4. Site Management Organizations Market in Asia-Pacific, 2021-2035
13.8.4.1. Site Management Organizations Market in China, 2021-2035
13.8.4.2. Site Management Organizations Market in Korea, 2021-2035
13.8.4.3. Site Management Organizations Market in India, 2021-2035
13.8.4.4. Site Management Organizations Market in Australia, 2021-2035
13.8.4.5. Site Management Organizations Market in Japan, 2021-2035
13.8.4.6. Site Management Organizations Market in Israel, 2021-2035
13.8.4.7. Site Management Organizations Market in Rest of Asia-Pacific, 2021-2035

13.8.5. Site Management Organizations Market in Latin America, 2021-2035
13.8.6. Site Management Organizations Market in MENA, 2021-2035
13.8.7. Site Management Organizations Market in Rest of the World, 2021-2035

14. CONCLUDING REMARKS

15. EXECUTIVE INSIGHTS
15.1. Chapter Overview
15.2. GDD Experts
15.2.1. Company Snapshot
15.2.2. Interview Transcript: Vinod Gyanchandani, Country Head-Clinical Operations

15.3. SMO – Dra. Marisa Vico
15.3.1. Company Snapshot
15.3.2. Interview Transcript: Marisa Vico, Medical Director and Operations Manager

15.4. Syncretic Clinical Research Services
15.4.1. Company Snapshot
15.4.2. Interview Transcript: Eugene Winifred, Project Manager

16. APPENDIX 1: TABULATED DATA

17. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures

Figure 2.1 Executive Summary: Market Forecast
Figure 2.2 Executive Summary: Overall Market Landscape
Figure 2.3 Executive Summary: Partnerships and Collaborations
Figure 2.4 Executive Summary: Funding and Investments
Figure 2.5 Executive Summary: Clinical Trial Key Insights
Figure 2.6 Executive Summary: Analysis of Demand for Clinical Trial Participants
Figure 3.1 Working Model of Site Management Organizations
Figure 3.2 Services Offered by Site Management Organizations
Figure 4.1 Site Management Organizations: Distribution by Year of Establishment
Figure 4.2 Site Management Organizations: Distribution by Company Size
Figure 4.3 Site Management Organizations: Distribution by Location of Headquarters (Region-wise)
Figure 4.4 Site Management Organizations: Distribution by Location of Headquarters (Country-wise)
Figure 4.5 Site Management Organizations: Distribution by Company Size and Location of Headquarters
Figure 4.6 Site Management Organizations: Distribution by Service(s) Offered
Figure 4.7 Site Management Organizations: Distribution by Location of Headquarters and Service(s) Offered
Figure 4.8 Site Management Organizations: Distribution by Therapeutic Expertise
Figure 4.9 Site Management Organizations: Distribution by Geographical Reach
Figure 5.1 Company Competitiveness Analysis: Small Players in North America
Figure 5.2 Company Competitiveness Analysis: Mid-sized Players in North America
Figure 5.3 Company Competitiveness Analysis: Large Players in North America
Figure 5.4 Company Competitiveness Analysis: Small Players in Europe
Figure 5.5 Company Competitiveness Analysis: Mid-sized Players in Europe
Figure 5.6 Company Competitiveness Analysis: Large Players in Europe
Figure 5.7 Company Competitiveness Analysis: Small Players in Asia-Pacific and Rest of the World
Figure 5.8 Company Competitiveness Analysis: Mid-sized Players in Asia-Pacific and Rest of the World
Figure 5.9 Company Competitiveness Analysis: Large Players in Asia-Pacific and Rest of the World
Figure 9.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2016-2021
Figure 9.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 9.3 Partnerships and Collaborations: Year-wise Trend by Type of Partnership
Figure 9.4 Partnerships and Collaborations: Distribution by Type of Partnership, 2016-2018 and 2019-2021
Figure 9.5 Partnerships and Collaborations: Distribution by Focus Area
Figure 9.6 Most Active Players: Distribution by Number of Partnerships
Figure 9.7 Partnerships and Collaborations: Distribution by Region
Figure 9.8 Partnerships and Collaborations: Distribution by Country
Figure 10.1 Funding and Investment Analysis: Cumulative Year-wise Trend, 2015-2021
Figure 10.2 Funding and Investment Analysis: Cumulative Year-wise Trend by Amount Invested, 2015-2021 (USD Million)
Figure 10.3 Funding and Investment Analysis: Distribution by Type of Funding
Figure 10.4 Funding and Investment Analysis: Distribution of Amount Invested by Type of Funding (USD Million)
Figure 10.5 Funding and Investment Analysis: Year-wise Distribution by Amount Invested and Type of Funding, 2015-2021 (USD Million)
Figure 10.6 Most Active Players: Distribution by Number of Funding Instances
Figure 10.7 Most Active Investors: Distribution by Number of Funding Instances
Figure 10.8 Funding and Investment Analysis: Distribution by Type of Investor
Figure 10.9 Funding and Investment Analysis: Distribution of Amount Invested by Type of Investor (USD Million)
Figure 10.10 Funding and Investment Analysis: Distribution by Region (Continent-wise)
Figure 10.11 Funding and Investment Analysis: Distribution by Region (Country-wise)
Figure 10.12 Funding and Investment Analysis: Distribution of Amount Invested by Region (Country-wise) (USD Million)
Figure 11.1 Clinical Trial Key Insights: Scope and Methodology
Figure 11.2 Clinical Trial Key Insights: Cumulative Distribution by Trial Registration Year, 2016-2021
Figure 11.3 Clinical Trial Key Insights: Distribution by Trial Registration Year and Enrolled Patient Population, 2016-2021
Figure 11.4 Clinical Trial Key Insights: Distribution by Trial Status
Figure 11.5 Clinical Trial Key Insights: Distribution by Trial Registration Year and Trial Status, 2016-2021
Figure 11.6 Clinical Trial Key Insights: Distribution of Number of Trials by Trial Phase
Figure 11.7 Clinical Trial Key Insights: Distribution of Enrolled Patient Population by Trial Phase
Figure 11.8 Clinical Trial Key Insights: Year-wise Distribution by Number of Trials and Trial Phase, 2016-2021
Figure 11.9 Clinical Trial Key Insights: Year-wise Distribution by Number of Enrolled Patient Population and Trial Phase, 2016-2021
Figure 11.10 Clinical Trial Key Insights: Distribution by Type of Sponsor / Collaborator
Figure 11.11 Clinical Trial Key Insights: Geographical Distribution by Number of Clinical Trials
Figure 11.12 Clinical Trial Key Insights: Geographical Distribution by Enrolled Patient Population
Figure 12.1 Analysis of Demand for Clinical Trial Participants: Scope and Methodology
Figure 12.2 Global Demand for Clinical Trial Participants, 2021-2035 (Million Patients)
Figure 12.3 Global Demand for Clinical Trial Participants, 2021-2035: Distribution by Therapeutic Area (Million Patients)
Figure 12.4 Global Demand for Clinical Trial Participants, 2021-2035: Distribution by Trial Phase (Million Patients)
Figure 12.5 Global Demand for Clinical Trial Participants, 2021: Distribution by Region (Million Patients)
Figure 13.1 Global Site Management Organizations Market, 2021-2035 (USD Billion)
Figure 13.2 Site Management Organizations Market, 2021 and 2035: Distribution by Therapeutic Area (USD Billion)
Figure 13.3 Site Management Organizations Market, 2021-2035: Distribution by Trial Phase (USD Billion)
Figure 13.4 Site Management Organizations Market, 2021: Distribution by Clinical Trial Components (USD Billion)
Figure 13.5 Site Management Organizations Market, 2021-2035: Distribution by Type of Intervention (USD Billion)
Figure 13.6 Site Management Organizations Market, 2021 and 2035: Distribution by Region (USD Billion)
Figure 13.7 Site Management Organizations Market, 2021 and 2035: Distribution by Country (USD Billion)
Figure 13.8 Site Management Organizations Market in North America, 2021-2035 (USD Billion)
Figure 13.9 Site Management Organizations Market in the US, 2021-2035 (USD Billion)
Figure 13.10 Site Management Organizations Market in Canada, 2021-2035 (USD Billion)
Figure 13.11 Site Management Organizations Market in Rest of North America, 2021-2035 (USD Billion)
Figure 13.12 Site Management Organizations Market in Europe, 2021-2035 (USD Billion)
Figure 13.13 Site Management Organizations Market in the UK, 2021-2035 (USD Billion)
Figure 13.14 Site Management Organizations Market in France, 2021-2035 (USD Billion)
Figure 13.15 Site Management Organizations Market in Germany, 2021-2035 (USD Billion)
Figure 13.16 Site Management Organizations Market in Spain, 2021-2035 (USD Billion)
Figure 13.17 Site Management Organizations Market in Italy, 2021-2035 (USD Billion)
Figure 13.18 Site Management Organizations Market in Rest of Europe, 2021-2035 (USD Billion)
Figure 13.19 Site Management Organizations Market in Asia-Pacific, 2021-2035 (USD Billion)
Figure 13.20 Site Management Organizations Market in China, 2021-2035 (USD Billion)
Figure 13.21 Site Management Organizations Market in Korea, 2021-2035 (USD Billion)
Figure 13.22 Site Management Organizations Market in India, 2021-2035 (USD Billion)
Figure 13.23 Site Management Organizations Market in Australia, 2021-2035 (USD Billion)
Figure 13.24 Site Management Organizations Market in Japan, 2021-2035 (USD Billion)
Figure 13.25 Site Management Organizations Market in Israel, 2021-2035 (USD Billion)
Figure 13.26 Site Management Organizations Market in Rest of Asia-Pacific, 2021-2035 (USD Billion)
Figure 13.27 Site Management Organizations Market in Latin America, 2021-2035 (USD Billion)
Figure 13.28 Site Management Organizations Market in MENA, 2021-2035 (USD Billion)
Figure 13.29 Site Management Organizations Market in Rest of the World, 2021-2035 (USD Billion)
Figure 14.1 Concluding Remarks: Overall Market Landscape
Figure 14.2 Concluding Remarks: Partnerships and Collaborations
Figure 14.3 Concluding Remarks: Funding and Investment
Figure 14.4 Concluding Remarks: Clinical Trial Key Insights
Figure 14.5 Concluding Remarks: Analysis of Demand for Clinical Trial Participants
Figure 14.6 Concluding Remarks: Market Forecast

List Of Tables

Table 3.1 Comparison of SMOs and CROs
Table 4.1 List of Site Management Organizations
Table 4.2 Site Management Organizations: Information on Type of Site Management Service(s) offered
Table 4.3 Site Management Organizations: Information on Therapeutic Expertise
Table 6.1 Site Management Organizations: List of Profiled Companies (North America)
Table 6.2 FOMAT Medical Research: Company Snapshot
Table 6.3 FOMAT Medical Research: Clinical Trial Site Management Service Portfolio
Table 6.4 FOMAT Medical Research: Recent Developments and Future Outlook
Table 6.5 Parexel: Company Snapshot
Table 6.6 Parexel: Clinical Trial Site Management Service Portfolio
Table 6.7 Paraxel: Recent Developments and Future Outlook
Table 6.8 Pharm-Olam: Company Snapshot
Table 6.9 Pharm-Olam: Clinical Trial Site Management Service Portfolio
Table 6.10 Pharm-Olam: Recent Developments and Future Outlook
Table 6.11 Veristat: Company Snapshot
Table 6.12 Veristat: Clinical Trial Site Management Service Portfolio
Table 6.13 Veristat: Recent Developments and Future Outlook
Table 6.14 WCCT Global: Company Snapshot
Table 6.15 WCCT Global: Clinical Trial Site Management Service Portfolio
Table 6.16 WCCT Global: Recent Developments and Future Outlook
Table 7.1 Site Management Organizations: List of Profiled Companies (Europe)
Table 7.2 CROMSOURCE: Company Snapshot
Table 7.3 CROMSOURCE: Clinical Trial Site Management Service Portfolio
Table 7.4 CROMSOURCE: Recent Developments and Future Outlook
Table 7.5 FIDELIS RESEARCH: Company Snapshot
Table 7.6 FIDELIS RESEARCH: Clinical Trial Site Management Service Portfolio
Table 7.7 FIDELIS RESEARCH: Recent Developments and Future Outlook
Table 7.8 Scandinavian CRO: Company Snapshot
Table 7.9 Scandinavian CRO: Clinical Trial Site Management Service Portfolio
Table 7.10 Scandinavian CRO: Recent Developments and Future Outlook
Table 7.11 TFS HealthScience: Company Snapshot
Table 7.12 TFS HealthScience: Clinical Trial Site Management Service Portfolio
Table 7.13 TFS HealthScience: Recent Developments and Future Outlook
Table 7.14 Trialbee: Company Snapshot
Table 7.15 Trialbee: Clinical Trial Site Management Service Portfolio
Table 7.16 Trialbee: Recent Developments and Future Outlook
Table 8.1 Site Management Organizations: List of Profiled Companies (Asia-Pacific)
Table 8.2 CMIC Group: Company Snapshot
Table 8.3 CMIC Group: Clinical Trial Site Management Service Portfolio
Table 8.4 CMIC Group: Recent Developments and Future Outlook
Table 8.5 George Clinical: Company Snapshot
Table 8.6 George Clinical: Clinical Trial Site Management Service Portfolio
Table 8.7 George Clinical: Recent Developments and Future Outlook
Table 8.8 Tigermed: Company Snapshot
Table 8.9 Tigermed: Clinical Trial Site Management Service Portfolio
Table 8.10 Tigermed: Recent Developments and Future Outlook
Table 8.11 Veeda Clinical Research: Company Snapshot
Table 8.12 Veeda Clinical Research: Clinical Trial Site Management Service Portfolio
Table 8.13 Veeda Clinical Research: Recent Developments and Future Outlook
Table 9.1 Site Management Organizations: List of Partnerships and Collaborations, 2016-2021
Table 10.1 Site Management Organizations: List of Funding and Investments, 2015-2021
Table 12.1 Global Demand for Clinical Trial Participants: Average Number of Patients Enrolled by Trial Phase
Table 16.1 Site Management Organizations: Distribution by Year of Establishment
Table 16.2 Site Management Organizations: Distribution by Company Size
Table 16.3 Site Management Organizations: Distribution by Location of Headquarters (Region-wise)
Table 16.4 Site Management Organizations: Distribution by Location of Headquarters (Country-wise)
Table 16.5 Site Management Organizations: Distribution by Company Size and Location of Headquarters
Table 16.6 Site Management Organizations: Distribution by Service(s) Offered
Table 16.7 Site Management Organizations: Distribution by Location of Headquarters and Service(s) Offered
Table 16.8 Site Management Organizations: Distribution by Therapeutic Expertise
Table 16.9 Site Management Organizations: Distribution by Geographical Reach
Table 16.10 Partnerships and Collaborations: Cumulative Year-wise Trend, 2016-2021
Table 16.11 Partnerships and Collaborations: Distribution by Type of Partnership
Table 16.12 Partnerships and Collaborations: Year-wise Trend by Type of Partnership
Table 16.13 Partnerships and Collaborations: Distribution by Type of Partnership, 2016-2018 and 2019-2021
Table 16.14 Partnerships and Collaborations: Distribution by Focus Area
Table 16.15 Most Active Players: Distribution by Number of Partnerships
Table 16.16 Partnerships and Collaborations: Distribution by Region
Table 16.17 Partnerships and Collaborations: Distribution by Country
Table 16.18 Funding and Investment Analysis: Cumulative Year-wise Trend, 2015-2021
Table 16.19 Funding and Investment Analysis: Cumulative Year-wise Trend by Amount Invested, 2015-2021 (USD Million)
Table 16.20 Funding and Investment Analysis: Distribution by Type of Funding
Table 16.21 Funding and Investment Analysis: Distribution of Amount Invested by Type of Funding (USD Million)
Table 16.22 Funding and Investment Analysis: Year-wise Distribution by Amount Invested and Type of Funding, 2015-2021 (USD Million)
Table 16.23 Most Active Players: Distribution by Number of Funding Instances
Table 16.24 Most Active Investors: Distribution by Number of Funding Instances
Table 16.25 Funding and Investment Analysis: Distribution by Type of Investor
Table 16.26 Funding and Investment Analysis: Distribution of Amount Invested by Type of Investor (USD Million)
Table 16.27 Funding and Investment Analysis: Distribution by Region (Continent-wise)
Table 16.28 Funding and Investment Analysis: Distribution by Region (Country-wise)
Table 10.29 Funding and Investment Analysis: Distribution of Amount Invested by Region (Country-wise) (USD Million)
Table 16.30 Clinical Trial Key Insights: Cumulative Distribution by Trial Registration Year, 2016-2021
Table 16.31 Clinical Trial Key Insights: Distribution by Trial Registration Year and Enrolled Patient Population, 2016-2021
Table 16.32 Clinical Trial Key Insights: Distribution by Trial Status
Table 16.33 Clinical Trial Key Insights: Distribution by Trial Registration Year and Trial Status, 2016-2021
Table 16.34 Clinical Trial Key Insights: Distribution of Number of Trials by Trial Phase
Table 16.35 Clinical Trial Key Insights: Distribution of Enrolled Patient Population by Trial Phase
Table 16.36 Clinical Trial Key Insights: Year-wise Distribution by Number of Trials and Trial Phase, 2016-2021
Table 16.37 Clinical Trial Key Insights: Year-wise Distribution by Number of Enrolled Patient Population and Trial Phase, 2016-2021
Table 16.38 Clinical Trial Key Insights: Distribution by Type of Sponsor / Collaborator
Table 16.39 Clinical Trial Key Insights: Geographical Distribution by Number of Clinical Trials
Table 16.40 Clinical Trial Key Insights: Geographical Distribution by Enrolled Patient Population
Table 16.41 Global Demand for Clinical Trial Participants, 2021-2035 (Million Patients)
Table 16.42 Global Demand for Clinical Trial Participants: Distribution by Therapeutic Area (Million Patients)
Table 16.43 Global Demand for Clinical Trial Participants: Distribution by Trial Phase (Million Patients)
Table 16.44 Global Demand for Clinical Trial Participants: Distribution by Region (Million Patients)
Table 16.45 Global Site Management Organizations Market, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.46 Site Management Organizations Market, 2021 and 2035: Distribution by Therapeutic Area (USD Billion)
Table 16.47 Site Management Organizations Market, 2021-2035: Distribution by Trial Phase (USD Billion)
Table 16.48 Site Management Organizations Market, 2021: Distribution by Clinical Trial Components (USD Billion)
Table 16.49 Site Management Organizations Market, 2021-2035: Distribution by Type of Intervention (USD Billion)
Table 16.50 Site Management Organizations Market, 2021 and 2035: Distribution by Region (USD Billion)
Table 16.51 Site Management Organizations Market, 2021 and 2035: Distribution by Country (USD Billion)
Table 16.52 Site Management Organizations Market in North America, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.53 Site Management Organizations Market in the US, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.54 Site Management Organizations Market in Canada, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.55 Site Management Organizations Market in Rest of North America, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.56 Site Management Organizations Market in Europe, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.57 Site Management Organizations Market in the UK, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.58 Site Management Organizations Market in France, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.59 Site Management Organizations Market in Germany, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.60 Site Management Organizations Market in Spain, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.61 Site Management Organizations Market in Italy, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.62 Site Management Organizations Market in Rest of Europe, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.63 Site Management Organizations Market in Asia-Pacific, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.64 Site Management Organizations Market in China, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.65 Site Management Organizations Market in Korea, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.66 Site Management Organizations Market in India, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.67 Site Management Organizations Market in Australia, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.68 Site Management Organizations Market in Japan, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.69 Site Management Organizations Market in Israel, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.70 Site Management Organizations Market in Rest of Asia-Pacific, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.71 Site Management Organizations Market in Latin America, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.72 Site Management Organizations Market in MENA, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.73 Site Management Organizations Market in Rest of the World, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)

List Of Companies

The following companies and organizations have been mentioned in the report.

1. 23andMe
2. 3H Medi Solution
3. 3S Pharma
4. Accel Clinical Services
5. Accell Clinical Research
6. Accelovance 
7. accerise
8. Access Clinical Research
9. Ace Research
10. ACI Clinical
11. Acrostar SMO
12. ACTG-CRO
13. Advanced Clinical
14. Aetion 
15. Affiliated Clinical Research
16. AiCure
17. Alpha Oncology Research (AOR)
18. Altasciences
19. Amadeus Capital Partners
20. AmberCRO
21. American Liver Foundation
22. American Research Associates (ARA)
23. AmerisourceBergen 
24. Analgesic Solutions
25. Andronovo Labs 
26. Anteris Bio
27. Antev 
28. Antidote
29. AOBiome Therapeutics
30. Apex Medical Research
31. APF Research
32. ApotheCom
33. Apptomics
34. Aptitude Health
35. Ardent Clinical Research Services
36. Asian Eye Institute
37. Associated Medical 
38. Association of Clinical Research Professionals (ACRP)
39. AstraZeneca 
40. Atlant Clinical
41. Aurum Clinical Research
42. AusTrials
43. AutoCruitment
44. Avacare 
45. AXELLE Group
46. AXIM Biotechnologies
47. BBK Worldwide
48. Beijing Aisimo Medical Science and Technology
49. Beijing CTSMED
50. Beijing EasyTrial MedTech 
51. Beijing Global Pharmaceutical Research (Acquired by EPS International)
52. Beijing Illness Challenge Foundation (ICF)
53. Best Clinical Practice
54. Bioclinica
55. Biomapas
56. Biomedical Advanced Research and Development Authority (BARDA)
57. Biomic Lifescience
58. Biosite Research
59. Box
60. BrainStorm Cell Therapeutics
61. Briban Invest
62. Bridge Clinical Research
63. BTC Network
64. Cactus Clinical Research
65. Calmark 
66. Canadian Centre for Clinical Trials (CCCT)
67. Cardialysis
68. CaringKind
69. Caris Life Sciences
70. Carpathian Research
71. Catalyst Regulatory Services (Acquired by Veristat)
72. CCT Research
73. Central India Clinical Research Services (CICRS) 
74. Centre International de Développement Pharmaceutique (CIDP)
75. Chase Medical Research
76. ChiG 
77. Chrondel 
78. Cidara Therapeutics
79. Cinven
80. Clariness 
81. Cliantha Research
82. Clin Sol 
83. Clinade Clinical Research
84. Clinart MENA
85. ClinChoice
86. ClinEdge 
87. Clinerion
88. Clinexa Life Sciences
89. Clinical Accelerator
90. Clinical Development Solutions (CDS)
91. Clinical Endpoints 
92. Clinical Investigation Centre (University Malaya Medical Centre)
93. Clinical Research Fastrack
94. Clinical Research Partners
95. Clinical Trial Networking (CT-N)
96. Clinical Trials Management Solutions (CTMS)
97. ClinicalConnection
98. Clinipace
99. CLINISYD 
100. Clinixir
101. ClinROtech
102. ClinSmart
103. Clinsol
104. Clinspire Research
105. Clintec
106. Clintract 
107. ClinVax 
108. Clinverse
109. ClinWin Research Services 
110. CLS-Ukraine
111. CluePoints
112. CMIC Group
113. CMX Research
114. CNS Pharmaceuticals
115. COD Research
116. Comac Medical
117. COMPASS Pathways
118. Compass Research
119. Continuum Clinical
120. Cosmic Clinical Services
121. Credevo 
122. Crestline Investors
123. CRO Pharmatrendz
124. Croissance Clinical Research
125. CROMSOURCE 
126. CRS Clinical Research Services
127. CTC North
128. CTI Clinical Trial and Consulting Services 
129. CTM
130. CX Partners
131. Cyclo Therapeutics
132. Cytespace 
133. DAC Patient Recruitment Services
134. Datavant
135. DAVA Oncology
136. DaVita Clinical Research
137. Deep Lens
138. Deerfield Management
139. DEMEDICA
140. Devana Solutions
141. DFnet
142. Dimension Research
143. Direct Biologics
144. dMed
145. Duke Clinical Research Institute (DCRI) 
146. eClinical Solutions
147. Edenwell Therapeutics
148. EDETEK
149. Effectus CTR
150. EGeen
151. Elligo Health Research
152. EMMES
153. emovis 
154. Empower Capital
155. EPS Associates
156. EPS International
157. EQT
158. ERT
159. ESTERN Medical 
160. Estudios Clínicos Latinoamérica (ECLA)
161. Ethicscare Clinical Research Services (ECRS)
162. EthosExcel
163. Everest Clinical Research
164. Evolution Research Group (ERG)
165. Experior 
166. F2 Ventures
167. FARMEPO
168. FDAMap
169. Febo
170. FedDev Ontario
171. FHI Clinical
172. Fidelis Research
173. FOMAT Medical Research
174. Foundation Medicine
175. Free to Breathe
176. Frenova Renal Research
177. Fresenius Medical Care
178. Gaea
179. Gama CRO
180. GB Sciences 
181. GCP Clinical Studies
182. GCP Research
183. G CURE Healthcare
184. GDD Experts
185. Genentech
186. General Atlantic
187. George Clinical
188. GIC
189. Global Clinical Trials
190. Goldman Sachs Asset Management International (GSAMI)
191. Gratisol Labs
192. GSK
193. GuideStar Research
194. Haihe Biopharma 
195. Hatteras Venture Partners
196. Haxon Life Sciences
197. Healing Hands Clinical Research Services (HHCRS)
198. HealthVerity
199. Horizon Research
200. Hospital Alemão Oswaldo Cruz 
201. EI Hospital de Especialidades Teodoro Maldonado Carbo
202. Hoth Therapeutics 
203. hyperCORE International
204. I’rom Group
205. iCo Therapeutics
206. iDD Research Solutions
207. IKCON PHARMA
208. Illingworth Research Group
209. InClin
210. Incred CR
211. Indian Institute of Clinical Research & Management (IICRM)
212. Industrifonden
213. Infectious Disease Research Institute (IDRI)
214. InformedDNA
215. Innoplexus 
216. Innovaderm
217. Innovate Research
218. Insignia Clinical Services (ICS)
219. INSPIRE
220. Integrity Capital Wealth Management
221. Inteliquet
222. International Research Networks (IRN)
223. Intouch Clinical Research Center 
224. Intrinsic Imaging (Acquired by WCG)
225. Invicro 
226. IPHARMA 
227. IQVIA
228. ITOCHU
229. ITOCHU Technology Ventures
230. Johnson Clinical Research
231. Juno Research
232. Karyopharm Therapeutics
233. Klinar CRO
234. KlinEra 
235. KMR Group
236. Komplett Clinical Research (KCR)
237. KPS Clinical Services
238. KV Clinical Research Services (KVCR)
239. Kyung Hee University Hospital 
240. LEADS Clinical Research and Bio Services
241. Limbix
242. Linical Americas
243. Link Health
244. LITMUS 
245. LiveRamp
246. LMC Manna Research
247. Lyft
248. MakroCare
249. Marshfield Clinic Research Institute
250. Mary Bird Perkins Cancer Center
251. Mayo Clinic
252. med fusion (Acquired by Quest Diagnostics)
253. Medable
254. MedAvante-ProPhase (Acquired by WCG)
255. MEDEX 
256. Median Technologies
257. Medicor Research
258. Medicus Alliance
259. Medicus Health Partners
260. Medidata 
261. Melanoma Research Alliance
262. MENE Health Group
263. Merck
264. Merck Global Health Innovation Fund (GHI)
265. Metrics Champion Consortium (MCC) (Acquired by WCG)
266. Mitsui
267. MMG
268. Molecular Templates
269. Montserrat Day Hospitals
270. MPM Capital
271. MPR Development Group
272. MTIP
273. Muscular Dystrophy Association (MDA)
274. National Cancer Center
275. National Institute of Clinical Research (NICR)
276. National Taiwan University Hospital (NTUH)
277. NeoGenomics
278. Newton Clinical Research
279. NextPhase Research
280. Nomad Life Sciences 
281. North Estonia Medical Centre
282. Novotech
283. nRollmed
284. Nucleon Therapeutics
285. O4 Research
286. Oaxaca Site Management Organization (OSMO)
287. Octopus Investments
288. Octopus Ventures
289. Okogen
290. OneOncology
291. Optimum CRO
292. Ora
293. Oracle
294. orphan reach
295. Orphanos
296. Ospedale San Raffaele
297. P3 Research
298. Panthera
299. Parallel 6 (Acquired by PRA Health Sciences)
300. Parexel 
301. PAS Research
302. PatientPoint 
303. Peachtree BioResearch Solutions
304. Penta ID Innovation
305. Pepgra
306. Pfizer
307. Pharmatech
308. Pharm-Olam 
309. phaware 
310. Physicians Research Group (PRG)
311. Plexus Research
312. Polaris Biopharma Consulting
313. PPC Group
314. PPD
315. Prabhans Clinical Services
316. Praxis
317. Precision for Medicine
318. Precision Health
319. Prime Site
320. Prodia 
321. Protocol First
322. ProTrials Research
323. Prudentia 
324. Psilera 
325. Puerto Rico Consortium for Clinical Investigation (PRCCI)
326. Pulse Clinical Research
327. Pusan National University Hospital (PNUH)
328. PWNHealth
329. QAscent Research Solutions
330. QPS
331. Quad-C Management
332. Quanticate 
333. Quantime World 
334. Quest Diagnostics 
335. Quintessential Solutions
336. Ravek 
337. RealTime Software Solutions
338. Red Maple Trials
339. RemediumOne 
340. Research Trials Group
341. RESolutions
342. Reumalab
343. Revive Therapeutics
344. Richmond Behavioral Associates (RBA)
345. Rock Springs Capital
346. Rutherford Health plc
347. S4 Research
348. Sabre Partners
349. Samahitha Research Solutions
350. Sandia Clinical Research
351. Sanjeevani 
352. Sanofi 
353. Santa Maria Gastroenterology
354. Scandinavian CRO 
355. S-Clinical
356. SDS Clinical
357. Sequoia Capital
358. SGS Life Science Services
359. Shanghai Shoujia Medical Clinical Research
360. SiChaGi Medical Solutions
361. SIGAL SMS
362. Signify Health
363. SitePartner
364. Skin Research Institute of Singapore (SRIS)
365. Skylight Health
366. Smedvig Capital
367. SMO – DRA. MARISA VICO 
368. SMO Clinical Research (SMO-India)
369. SMO ClinPlus
370. SMO UCT
371. SMOconnect 
372. Smooth Drug Development
373. SMO-Pharmina 
374. Society for Clinical Research Sites
375. Solutions OP
376. Somaya Research and Health Services
377. SoMex Research & Health Organisation
378. Sonic Clinical Trials
379. Spectral Medical
380. Spectrum Clinical Research
381. Spero Oncology (Acquired by Veristat)
382. SPRI Ukraine
383. Springhill Fund
384. SQN Clinical
385. Statistics Collaborative
386. Superstring Capital
387. Surescripts
388. Syncretic Clinical Research Services
389. Syneos Health
390. Syntax 
391. Synteract
392. Syreon 
393. Takeda Pharmaceutical
394. Terveystalo
395. TFS HealthScience
396. Association of Clinical Research Professionals (ACRP)
397. The Buffalo-Niagara Clinical Alliance (BNCA)
398. The Clinical Trial Company (TCTC) (Acquired by Veristat)
399. The Clinic'les
400. THREAD
401. ThreeWire
402. Tigermed
403. Tiziana Life Sciences
404. Topstone Research
405. Total Clinical Trial Management
406. Translational Research in Oncology (TRIO)
407. Trial Management Group (TMG)
408. Trialbee
409. TrialSpark
410. Trifecta (acquired by WCG)
411. TriNetX
412. Triumph Research Intelligence (TRI)
413. Triumpharma 
414. United States Department of Defense (DOD)
415. uMotif
416. Unicorn Protego Site Management Organization (UP SMO)
417. United BioSource (UBC)
418. University of Yamanshi 
419. Urgent Care Clinical Trials
420. Vector Oncology
421. Veeda Clinical Research
422. Veeva Systems
423. VeraSci
424. Veristat 
425. Vicore Pharma
426. Vigilare International
427. Viomedo
428. Virgo
429. Walter and Eliza Hall Institute of Medical Research (WEHI)
430. WCCT Global
431. WCG
432. WCG Avoca
433. WCG PharmaSeek
434. WindRose Health Investors
435. Worldwide Clinical Trials
436. WuXi Clinical (a WuXi AppTec Company)
437. Xcene Research
438. Xylem Clinical Research 
439. Zagvo Portal
440. Zarta Life
441. Zosano Pharma